Approval · Notice of Compliance 9397 · 2008
AGGRENOX: Notice of Compliance 9397
Issued February 18, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9397
- Date
- February 18, 2008
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph: dosage and administration, action and clinical pharmacology and labelling
- Therapeutic class
- Combination antiplatelet agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AGGRENOX | Not yet assigned | — |
Medicinal ingredients
- ACETYLSALICYLIC ACID 25 MG per CAP
- DIPYRIDAMOLE 200 MG per CAP